MedTrace Logo

Telehealth and Home-based Exercise and Rehabilitation Therapy for Acute Coronary Syndrome

NCT06473441 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2024-06-25

No results posted yet for this study

Summary

This study aims to compare the effectiveness of three different home-based rehabilitation programs for patients with acute coronary syndrome (ACS). This randomized controlled trial will recruit 60 ACS patients, divided into three groups: a 12-week home rehabilitation group, a 6-week tele-rehabilitation followed by 6-week home rehabilitation group, and a 12-week tele-rehabilitation combined with home rehabilitation group. Patients will be assessed at baseline, and at 3, 6, and 12 months on physical health, cardiopulmonary function, and psychological well-being. The hypothesis is that home-based CR, particularly with tele-rehabilitation, will improve recovery and quality of life more effectively. The study aims to identify the most beneficial home rehabilitation strategy for ACS patients.

Conditions

Interventions

BEHAVIORAL

Tele-Rehabilitation Therapy

Twice-weekly sessions with remote supervision and guidance from therapists.

BEHAVIORAL

Health Education

Health education based on individual assessments.

BEHAVIORAL

Exercise Prescription

Exercise prescription tailored to individual needs.

BEHAVIORAL

Home Exercise Equipment Use

Use of a home exercise bike, resistance bands, respiratory muscle training device, and a portable heart rate monitor.

BEHAVIORAL

Exercise Log

Logging daily exercise intensity and duration in a rehabilitation diary

BEHAVIORAL

Follow-Up Calls

Regular follow-up calls to monitor progress and address any issues.

Sponsors & Collaborators

  • National Taiwan University Hospital

    lead OTHER

Principal Investigators

  • Shu-mei Yang, MD · National Taiwan University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-07-01
Primary Completion
2026-06-30
Completion
2027-06-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06473441 on ClinicalTrials.gov